Synopsis
Synopsis
0
KDMF
0
NDC API
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Calciofon
2. Calcipot
3. Calcium Braun
4. Calcivitol
5. Calglucon
6. Cbg
7. Ebucin
8. Flopak Plain
9. Glucal
10. Glucobiogen
11. Gluconate De Calcium Lavoisier
12. Gluconate, Calcium
13. Gluconato Calc Fresenius
1. 299-28-5
2. Calcium D-gluconate
3. Calglucon
4. D-gluconic Acid, Calcium Salt (2:1)
5. Gluconate Calcium
6. Calcarea Gluconica
7. Calcium Di-gluconate
8. Calcium Gluconate Anhydrous
9. Gluconic Acid Calcium Salt
10. Calcium Gluconate, Anhydrous
11. Glucobiogen
12. Calciofon
13. Sqe6vb453k
14. Ins No.578
15. Ebucin
16. Gluconate De Calcium
17. Ins-578
18. Almora
19. Nsc-744619
20. 152772-65-1
21. Calcium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate
22. Calcicol
23. Calcipur
24. Calglucol
25. Dragocal
26. Kalpren
27. Novocal
28. E-578
29. Calcium (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate
30. Calcium Hexagluconate
31. 2,3,4,5,6-pentahydroxycaproic Acid Hemicalcium Salt
32. 18016-24-5
33. Gluconato Di Calcio
34. Calcium D-gluconate (1:2)
35. Gluconate De Calcium [french]
36. Gluconato Di Calcio [italian]
37. Ccris 1336
38. Hsdb 994
39. Calcium Gluconate [usan:jan]
40. Einecs 206-075-8
41. Unii-sqe6vb453k
42. Gluconic Acid, Calcium Salt
43. Calcii Gluconas
44. Gluconic Acid, Calcium Salt (2:1), D-
45. Gluconic Acid, Calcium Salt, D-
46. Mfcd00064209
47. Calcium Bis(d-gluconate)
48. Calcium Gluconate (usp)
49. L-gluconic Acid Calcium Salt
50. Schembl24132
51. Gluconic Acid Hemicalcium Salt
52. Calcium Gluconate [mi]
53. Chebi:3309
54. Calcium Gluconate [fcc]
55. Boron Gluconate Blend 5% 40m
56. Calcium Gluconate [hsdb]
57. Calcium Gluconate [inci]
58. Chembl2106119
59. Dtxsid2029618
60. Calcium Gluconate [vandf]
61. Calcium Gluconate [who-dd]
62. Calcium Gluconate [who-ip]
63. Akos015895893
64. Calcii Gluconas [who-ip Latin]
65. Calcium Gluconate [orange Book]
66. Db11126
67. Nsc 744619
68. Calcium Gluconate [usp Impurity]
69. Calcium Gluconate [usp Monograph]
70. As-80559
71. Calcium Gluconate Anhydrous [usp-rs]
72. G0037
73. C08133
74. D00935
75. A876351
76. Q413739
77. Calcium Gluconate, Anhydrous [ep Monograph]
78. W-202243
79. Calcium D-gluconate Gel, 2.5% W/w Aqueous Solution
80. Calcium Bis[(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate]
| Molecular Weight | 430.37 g/mol |
|---|---|
| Molecular Formula | C12H22CaO14 |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 8 |
| Exact Mass | 430.0635462 g/mol |
| Monoisotopic Mass | 430.0635462 g/mol |
| Topological Polar Surface Area | 283 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 165 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Some studies have shown that calcium supplementation begun in the second trimester may be effective in lowering blood pressure in pregnancy women with pregnancy-induced hypertension or pre-eclampsia, both of which may possibly be associated with increased calcium demand of the fetus during the last trimester. /Calcium supplements/
USP Convention. USPDI-Drug Information for the Health Care Professional. 14th ed. Volume I. Rockville, MD: United States Pharmacopeial Convention, Inc., 1994. (Plus Updates)., p. 698
Oral calcium salts are used as dietary supplemental therapy for person who may not get enough calcium in their regular diet. Due to increased needs, children and pregnancy women are at greatest risk. Pre- and postmenopausal women; adolescents, especially girls and the elderly may not receive adequate calcium in their diets. ... Calcium supplements are used as part of the prevention and treatment of osteoporosis in patients with an inadequate calcium intake. The use of calcium citrate may reduce the risk of kidney stones in susceptible patients. The use of water-soluble salts of calcium (ie, citrate, gluconate, and lactate) may be preferable to acid-soluble salts (ie, carbonate and phosphate) for patients with reduced stomach acid or patients taking acid-inhibiting medication, such as the histamine H2-receptor antagonists. /Calcium supplements; Included in US product labeling/
Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 742
Oral calcium supplements provide a source of calcium ion for treating calcium depletion occurring in conditions such as chronic hypoparathyroidism, pseudohypoparathyroidism, osteomalacia, rickets, chronic renal failure, and hypocalcemia secondary to the administration of anticonvulsant medications. When chronic hypocalcemia is due to vitamin D deficiency oral calcium salts may be administered concomitantly with vitamin D analogs. /Calcium supplements; Included in US product labeling/
Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 742
Calcium chloride and parenteral calcium gluconate are used to decrease or reverse the cardiac depressant effects of hyperkalemia on electrocardiographic (ECG) function. /Calcium supplements; Included in US product labeling/
Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 742
For more Therapeutic Uses (Complete) data for CALCIUM GLUCONATE (27 total), please visit the HSDB record page.
VET: ... Calcium gluconate ... if given by iv injection, should be admin slowly ... given rapidly ... may have toxic effect on heart.
Clarke, E.G., and M. L. Clarke. Veterinary Toxicology. Baltimore, Maryland: The Williams and Wilkins Company, 1975., p. 47
Calcium gluconate ... not recommended for im use because dose must be large and danger of sterile abscess formation is too great.
Hayes, W.J., Jr., E.R. Laws Jr., (eds.). Handbook of Pesticide Toxicology Volume 1. General Principles. New York, NY: Academic Press, Inc., 1991., p. 398
Many physicians recommend that pregnant women receive multivitamin and mineral supplements, especially those pregnant women who do not consume an adequate diet and those in high-risk categories )ie, women carrying more than one fetus, heavy cigarette smokers, and alcohol and drug abusers). Taking excessive amounts of a multivitamin and mineral supplement may be harmful to the mother and/or fetus and should be avoided. /Calcium supplements/
Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 742
Side/adverse effects may be more likely to occur if oral calcium supplements are taken in much larger doses than recommended (greater than 2000 to 2500 mg a day), if they are taken for a longer period of time, or if they are taken by patients with renal function impairment or milk-alkali syndrome. /Calcium supplements/
Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 744
For more Drug Warnings (Complete) data for CALCIUM GLUCONATE (15 total), please visit the HSDB record page.
Oral calcium salts are used as dietary supplemental therapy for person who may not get enough calcium in their regular diet. Calcium gluconate is used as a cardioprotective agent in high blood potassium. Calcium gluconate is the antidote for magnesium sulfate toxicity.
Calcium Gluconate is the gluconate salt of calcium. An element or mineral necessary for normal nerve, muscle, and cardiac function, calcium as the gluconate salt helps to maintain calcium balance and prevent bone loss when taken orally. This agent may also be chemopreventive for colon and other cancers.
A - Alimentary tract and metabolism
A12 - Mineral supplements
A12A - Calcium
A12AA - Calcium
A12AA03 - Calcium gluconate
D - Dermatologicals
D11 - Other dermatological preparations
D11A - Other dermatological preparations
D11AX - Other dermatologicals
D11AX03 - Calcium gluconate
Absorption
Approximately one-fifth to one-third of orally administered calcium is absorbed in the small intestine, depending on presence of vitamin D metabolites, pH in lumen, and on dietary factors, such as calcium binding to fiber or phytates. Calcium absorption is increased when a calcium deficiency is present or when a patient is on a low-calcium diet. In patients with achlorhydria or hypochlorhydria, calcium absorption, especially with the carbonate salt, may be reduced.
Route of Elimination
Renal (20%) - The amount excreted in the urine varies with degree of calcium absorption and whether there is excessive bone loss or failure of renal conservation. Fecal (80%) - Consists mainly of nonabsorbed calcium, with only a small amount of endogenous fecal calcium excreted.
Volume of Distribution
Not available
Approximately one-fifth to one-third of orally administered calcium is absorbed in the small intestine, depending on presence of vitamin D metabolites, pH in lumen, and on dietary factors, such as calcium binding to fiber or phytates. Calcium absorption is increased when a calcium deficiency is present or when a patient is on a low-calcium diet. In patients with achlorhydria or hypochlorhydria, calcium absorption, especially with the carbonate salt, may be reduced. /Calcium supplements/
Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 742
Elimination: Renal (20%) - The amount excreted in the urine varies with degree of calcium absorption and whether there is excessive bone loss or failure of renal conservation. Fecal (80%) - Consists mainly of nonabsorbed calcium, with only a small amount of endogenous fecal calcium excreted. /Calcium supplements/
Thomson/Micromedex. Drug Information for the Health Care Professional. Volume 1, Greenwood Village, CO. 2006., p. 742
Calcium gluconate does not require hepatic metabolism for the release of Ca++ and is as effective as calcium chloride in treating ionic hypocalcemia in the absence of hepatic function.
Calcium is essential for the functional integrity of the nervous, muscular, and skeletal systems. It plays a role in normal cardiac function, renal function, respiration, blood coagulation, and cell membrane and capillary permeability. Also, calcium helps to regulate the release and storage of neurotransmitters and hormones, the uptake and binding of amino acids, absorption of vitamin B 12, and gastrin secretion. The major fraction (99%) of calcium is in the skeletal structure primarily as hydroxyapatite, Ca 10(PO 4) 6(OH) 2; small amounts of calcium carbonate and amorphous calcium phosphates are also present. The calcium of bone is in a constant exchange with the calcium of plasma. Since the metabolic functions of calcium are essential for life, when there is a disturbance in the calcium balance because of dietary deficiency or other causes, the stores of calcium in bone may be depleted to fill the body's more acute needs. Therefore, on a chronic basis, normal mineralization of bone depends on adequate amounts of total body calcium.
API SUPPLIERS
Click Us!
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-07-13
Pay. Date : 2021-05-26
DMF Number : 34748
Submission : 2021-06-01
Status : Active
Type : II
Certificate Number : R1-CEP 2012-068 - Rev 01
Issue Date : 2023-02-20
Type : Chemical
Substance Number : 979
Status : Valid
Registration Number : 305MF10100
Registrant's Address : No. 578, Binhai Ten Road, Economic and Technological Development Zone, Wenzhou, Zhejiang Province, China
Initial Date of Registration : 2023-08-22
Latest Date of Registration : --
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31690
Submission : 2017-05-23
Status : Active
Type : II
Registration Number : 217MF10521
Registrant's Address : Tokushima Prefecture Naruto City Setocho Myojin Maruyama 85-1
Initial Date of Registration : 2005-09-07
Latest Date of Registration : --
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38969
Submission : 2023-10-09
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-05-25
Pay. Date : 2022-03-24
DMF Number : 36938
Submission : 2022-04-12
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-10-24
Pay. Date : 2023-10-03
DMF Number : 37213
Submission : 2023-07-05
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-03-10
Pay. Date : 2022-03-07
DMF Number : 29432
Submission : 2015-05-28
Status : Active
Type : II
Certificate Number : R1-CEP 2016-091 - Rev 00
Issue Date : 2022-10-25
Type : Chemical
Substance Number : 979
Status : Valid
Date of Issue : 2022-06-08
Valid Till : 2025-07-07
Written Confirmation Number : WC-0104
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35940
Submission : 2021-05-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8438
Submission : 1990-02-05
Status : Inactive
Type : II
Certificate Number : R1-CEP 2012-094 - Rev 01
Issue Date : 2018-09-27
Type : Chemical
Substance Number : 979
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24708
Submission : 2010-12-20
Status : Inactive
Type : II
Registration Number : 306MF10018
Registrant's Address : Tokushima Prefecture Naruto City Setocho Myojin Maruyama 85-1
Initial Date of Registration : 2024-01-30
Latest Date of Registration : --
Certificate Number : R1-CEP 1995-020 - Rev 07
Issue Date : 2009-05-28
Type : Chemical
Substance Number : 172
Status : Withdrawn by Holder
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8438
Submission : 1990-02-05
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-10-24
Pay. Date : 2023-10-03
DMF Number : 37213
Submission : 2023-07-05
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-03-10
Pay. Date : 2022-03-07
DMF Number : 29432
Submission : 2015-05-28
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-05-25
Pay. Date : 2022-03-24
DMF Number : 36938
Submission : 2022-04-12
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31690
Submission : 2017-05-23
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24708
Submission : 2010-12-20
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35940
Submission : 2021-05-27
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2021-07-13
Pay. Date : 2021-05-26
DMF Number : 34748
Submission : 2021-06-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38969
Submission : 2023-10-09
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
Certificate Number : R1-CEP 2012-095 - Rev 01
Status : Valid
Issue Date : 2018-11-23
Type : Chemical
Substance Number : 172
Calcium Gluconate For Injection
Certificate Number : R1-CEP 2012-094 - Rev 01
Status : Valid
Issue Date : 2018-09-27
Type : Chemical
Substance Number : 979
Calcium Gluconate For Injection
Certificate Number : R1-CEP 2001-246 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2009-05-28
Type : Chemical
Substance Number : 979
Certificate Number : R1-CEP 1995-020 - Rev 07
Status : Withdrawn by Holder
Issue Date : 2009-05-28
Type : Chemical
Substance Number : 172
Calcium Gluconate For Injection
Certificate Number : R1-CEP 2016-091 - Rev 00
Status : Valid
Issue Date : 2022-10-25
Type : Chemical
Substance Number : 979
Calcium Gluconate For Injection
Certificate Number : R1-CEP 2005-298 - Rev 00
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2012-10-01
Type : Chemical
Substance Number : 979
Certificate Number : R1-CEP 2002-128 - Rev 00
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2008-12-04
Type : Chemical
Substance Number : 172
Certificate Number : R0-CEP 2016-029 - Rev 00
Status : Expired
Issue Date : 2017-07-18
Type : Chemical
Substance Number : 172
Calcium Gluconate For Injection
Certificate Number : R0-CEP 2020-039 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2021-04-29
Type : Chemical
Substance Number : 979
Calcium Gluconate For Injection
Certificate Number : R1-CEP 2012-068 - Rev 01
Status : Valid
Issue Date : 2023-02-20
Type : Chemical
Substance Number : 979
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - SOLUTION;INTRAVENOUS - 10GM/100ML (1...DOSAGE - SOLUTION;INTRAVENOUS - 10GM/100ML (100MG/ML)
USFDA APPLICATION NUMBER - 208418
DOSAGE - SOLUTION;INTRAVENOUS - 1GM/10ML (100...DOSAGE - SOLUTION;INTRAVENOUS - 1GM/10ML (100MG/ML)
USFDA APPLICATION NUMBER - 208418
DOSAGE - SOLUTION;INTRAVENOUS - 1GM/50ML (20M...DOSAGE - SOLUTION;INTRAVENOUS - 1GM/50ML (20MG/ML)
USFDA APPLICATION NUMBER - 208418
DOSAGE - SOLUTION;INTRAVENOUS - 2GM/100ML (20...DOSAGE - SOLUTION;INTRAVENOUS - 2GM/100ML (20MG/ML)
USFDA APPLICATION NUMBER - 208418
DOSAGE - SOLUTION;INTRAVENOUS - 5GM/50ML (100...DOSAGE - SOLUTION;INTRAVENOUS - 5GM/50ML (100MG/ML)
USFDA APPLICATION NUMBER - 208418
Related Excipient Companies
Evonik
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Direct Compression
Thickeners and Stabilizers
Lubricants & Glidants
Parenteral
Co-Processed Excipients
Disintegrants & Superdisintegrants
Granulation
Controlled & Modified Release
Taste Masking
Topical
Chewable & Orodispersible Aids
Coating Systems & Additives
Emulsifying Agents
Film Formers & Plasticizers
Rheology Modifiers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Calcium Gluconate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Calcium Gluconate, including repackagers and relabelers. The FDA regulates Calcium Gluconate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Calcium Gluconate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Calcium Gluconate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Calcium Gluconate supplier is an individual or a company that provides Calcium Gluconate active pharmaceutical ingredient (API) or Calcium Gluconate finished formulations upon request. The Calcium Gluconate suppliers may include Calcium Gluconate API manufacturers, exporters, distributors and traders.
click here to find a list of Calcium Gluconate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Calcium Gluconate DMF (Drug Master File) is a document detailing the whole manufacturing process of Calcium Gluconate active pharmaceutical ingredient (API) in detail. Different forms of Calcium Gluconate DMFs exist exist since differing nations have different regulations, such as Calcium Gluconate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Calcium Gluconate DMF submitted to regulatory agencies in the US is known as a USDMF. Calcium Gluconate USDMF includes data on Calcium Gluconate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Calcium Gluconate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Calcium Gluconate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Calcium Gluconate Drug Master File in Japan (Calcium Gluconate JDMF) empowers Calcium Gluconate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Calcium Gluconate JDMF during the approval evaluation for pharmaceutical products. At the time of Calcium Gluconate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Calcium Gluconate suppliers with JDMF on PharmaCompass.
A Calcium Gluconate CEP of the European Pharmacopoeia monograph is often referred to as a Calcium Gluconate Certificate of Suitability (COS). The purpose of a Calcium Gluconate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Calcium Gluconate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Calcium Gluconate to their clients by showing that a Calcium Gluconate CEP has been issued for it. The manufacturer submits a Calcium Gluconate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Calcium Gluconate CEP holder for the record. Additionally, the data presented in the Calcium Gluconate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Calcium Gluconate DMF.
A Calcium Gluconate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Calcium Gluconate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Calcium Gluconate suppliers with CEP (COS) on PharmaCompass.
A Calcium Gluconate written confirmation (Calcium Gluconate WC) is an official document issued by a regulatory agency to a Calcium Gluconate manufacturer, verifying that the manufacturing facility of a Calcium Gluconate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Calcium Gluconate APIs or Calcium Gluconate finished pharmaceutical products to another nation, regulatory agencies frequently require a Calcium Gluconate WC (written confirmation) as part of the regulatory process.
click here to find a list of Calcium Gluconate suppliers with Written Confirmation (WC) on PharmaCompass.
Calcium Gluconate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Calcium Gluconate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Calcium Gluconate GMP manufacturer or Calcium Gluconate GMP API supplier for your needs.
A Calcium Gluconate CoA (Certificate of Analysis) is a formal document that attests to Calcium Gluconate's compliance with Calcium Gluconate specifications and serves as a tool for batch-level quality control.
Calcium Gluconate CoA mostly includes findings from lab analyses of a specific batch. For each Calcium Gluconate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Calcium Gluconate may be tested according to a variety of international standards, such as European Pharmacopoeia (Calcium Gluconate EP), Calcium Gluconate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Calcium Gluconate USP).
LOOKING FOR A SUPPLIER?
